Clinical Decision Support Systems Market
PUBLISHED: 2024 ID: SMRC24817
SHARE
SHARE

Clinical Decision Support Systems Market

Clinical Decision Support Systems Market Forecasts to 2030 - Global Analysis By Product Type (Knowledge-Based Systems, Non-Knowledge-Based Systems, Interoperable Systems and Other Product Types), Component, Mode of Delivery, Application, End User and By Geography

4.9 (96 reviews)
4.9 (96 reviews)
Published: 2024 ID: SMRC24817

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $1.7 BN

Projected Year Value (2030)

US $3.2 BN

CAGR (2023 - 2030)

9.5%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific


According to Stratistics MRC, the Global Clinical Decision Support Systems Market is accounted for $1.7 billion in 2023 and is expected to reach $3.2 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Clinical Decision Support Systems (CDSS) are computer-based tools or software designed to assist healthcare professionals in making clinical decisions by providing relevant information and knowledge at the point of care. These systems integrate patient data, medical knowledge, and best practices to offer recommendations, reminders, or alerts to aid in diagnosis, treatment, and management of patients. The goal is to improve healthcare outcomes, enhance patient safety, and support clinicians in delivering more informed and efficient care.

According to The Office of the National Coordinator for Health Information Technology (ONC), as of 2021, in the US approximately 96 percent of non-federal acute care hospitals and nearly 4 in 5 office-based physicians (78%) have implemented a certified Electronic Health Record (EHR) system.

Market Dynamics: 

Driver: 

Rising demand for quality healthcare

The market experiences escalating demand owing to a growing emphasis on superior healthcare provision. As healthcare complexities rise, CDSS emerges as a critical solution, aiding clinicians in making informed decisions, improving patient outcomes, and reducing errors. The market's expansion reflects the increasing need for advanced technology integration within healthcare systems, enabling efficient data analysis, personalized patient care, and streamlined decision-making processes, fostering a higher standard of healthcare delivery.

Restraint:

Data quality and accessibility

The market continually emphasizes enhancing data accuracy, completeness, and accessibility to ensure optimal system functionality. This involves integrating diverse data sources, implementing robust validation processes, and prioritizing interoperability for seamless information exchange. As it evolves, emphasis on data quality and accessibility remains pivotal, fostering trust among healthcare professionals and enabling informed, precise clinical decisions. These are the factors restraining the growth of the market.

Opportunity:

Increasing data availability

The market is witnessing a surge in data availability, catalyzed by advancements in health tech, interoperability standards, and digital health records. This influx encompasses diverse patient data, including genomic information, real-time monitoring, and comprehensive medical histories. Enhanced data accessibility empowers these systems to offer more precise, personalized recommendations, fostering improved healthcare outcomes and treatment strategies while promoting efficiency and accuracy in clinical decision-making processes.

Threat:

Costs and resource constraints

Development demands substantial investment in advanced technology, skilled personnel, and extensive clinical data. Implementation incurs expenses related to customization, integration with existing healthcare systems, and ongoing maintenance. Resource limitations, including access to high-quality data and expertise in algorithm development, hinder CDSS scalability and innovation. Balancing cost-effectiveness with optimal functionality poses a significant hurdle in this market. 

Covid-19 Impact: 

The COVID-19 pandemic significantly accelerated the adoption and development of Clinical Decision Support Systems (CDSS) globally. The increased reliance on telemedicine and remote healthcare services amplified the need for advanced CDSS, driving market growth. These systems aided healthcare professionals in managing patient data, improving diagnostic accuracy, and optimizing treatment plans. The pandemic highlighted the importance of efficient and data-driven healthcare solutions, leading to an expansion in the market and innovation in this sector.

The interoperable systems segment is expected to be the largest during the forecast period

The interoperable systems segment is expected to be the largest during the forecast period. These systems prioritize compatibility, enabling diverse healthcare software to communicate effectively. Interoperability ensures fluid exchange of patient information, enhancing accuracy and efficiency in clinical decision-making. The market trend emphasizes CDSS solutions that can interconnect with various healthcare technologies, optimizing data utilization for informed medical interventions.

The drug allergy alerts segment is expected to have the highest CAGR during the forecast period

The drug allergy alerts segment is expected to have the highest CAGR during the forecast period. One major benefit of these systems is that their ability to deliver allergy alerts is becoming more and more significant, as many people have allergies to particular medications. The number of patients experiencing medication allergies is on the rise. As a result, giving medication to a patient who has been given it may have negative effects and further damage the patient's case.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the increasing demand for information technology solutions in the health care industry. There's an increased importance for providing quality healthcare and rapid technological advancements these factors help in providing for the growth of the market in this region. The market expansion in this area is also fueled by the quick development of technology and the growing significance of offering high-quality healthcare services. 

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to increased R&D spending by governments of key nations. There are increasing investments in the healthcare sector in various countries like India China Japan and Australia. Improved research and development techniques and the expenditure and investments by the government in this field are the reasons which are helping increasing the penetration of information technology in the medical industry. 

Key players in the market

Some of the key players in Clinical Decision Support Systems market include McKesson Corporation, Koninklijke Philips N.V., Cerner Corporation, Allscripts Healthcare, LLC, Siemens Healthineers GmbH, NextGen Healthcare Inc., Wolters Kluwer N.V., Agfa-Gevaert Group, Athenahealth, Inc., IBM Corporation, Change Healthcare, Meditech, Epic Systems Corporation, and Carestream.

Key Developments:

In April 2023, Elsevier B.V. (UK) announced the launch of an upgraded version of its clinical decision support solution, ClinicalKey. This enhanced platform incorporates a comprehensive drug compendium, a cutting-edge mobile application, and seamless integration into Electronic Health Records (EHR).

In December 2022, Athenahealth (US) announced that it had released enhancements to its athenaOne EHR to facilitate immediate administration of COVID-19 vaccines. The rollout includes communications, scheduling, workflow, documentation, and reporting capabilities.

In April 2022, Change Healthcare (US) launched a new edition of InterQual 2022, the firm’s flagship clinical decision support solution for delivering the latest evidence-based appropriate care.

Product Types Covered:
• Knowledge-Based Systems
• Non-Knowledge-Based Systems
• Interoperable Systems
• Other Product Types 

Components Covered:
• Software
• Hardware
• Services 

Mode of Deliveries Covered:
• On Premise
• Web Based
• Cloud Based

Applications Covered:
• Drug Allergy Alerts
• Drug-Drug Interactions
• Clinical Reminders
• Clinical Guidelines
• Drug Dosing Support
• Other Applications

End Users Covered:
• Pharmacies
• Hospitals
• Clinics
• Diagnostic Centers
• Ambulatory Surgical Centres
• Other End Users 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary      
        
2 Preface       
 2.1 Abstract      
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 Product Analysis     
 3.7 Application Analysis    
 3.8 End User Analysis     
 3.9 Emerging Markets     
 3.10 Impact of Covid-19     
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Clinical Decision Support Systems Market, By Product Type 
 5.1 Introduction     
 5.2 Knowledge-Based Systems    
 5.3 Non-Knowledge-Based Systems   
 5.4 Interoperable Systems    
 5.5 Other Product Types    
        
6 Global Clinical Decision Support Systems Market, By Component 
 6.1 Introduction     
 6.2 Software      
 6.3 Hardware     
 6.4 Services      
        
7 Global Clinical Decision Support Systems Market, By Mode of Delivery 
 7.1 Introduction     
 7.2 On Premise     
 7.3 Web Based     
 7.4 Cloud Based     
        
8 Global Clinical Decision Support Systems Market, By Application 
 8.1 Introduction     
 8.2 Drug Allergy Alerts     
 8.3 Drug-Drug Interactions    
 8.4 Clinical Reminders     
 8.5 Clinical Guidelines     
 8.6 Drug Dosing Support    
 8.7 Other Applications     
        
9 Global Clinical Decision Support Systems Market, By End User  
 9.1 Introduction     
 9.2 Pharmacies     
 9.3 Hospitals      
 9.4 Clinics      
 9.5 Diagnostic Centers     
 9.6 Ambulatory Surgical Centres    
 9.7 Other End Users     
        
10 Global Clinical Decision Support Systems Market, By Geography 
 10.1 Introduction     
 10.2 North America     
  10.2.1 US     
  10.2.2 Canada     
  10.2.3 Mexico     
 10.3 Europe      
  10.3.1 Germany     
  10.3.2 UK     
  10.3.3 Italy     
  10.3.4 France     
  10.3.5 Spain     
  10.3.6 Rest of Europe    
 10.4 Asia Pacific     
  10.4.1 Japan     
  10.4.2 China     
  10.4.3 India     
  10.4.4 Australia     
  10.4.5 New Zealand    
  10.4.6 South Korea    
  10.4.7 Rest of Asia Pacific    
 10.5 South America     
  10.5.1 Argentina    
  10.5.2 Brazil     
  10.5.3 Chile     
  10.5.4 Rest of South America   
 10.6 Middle East & Africa    
  10.6.1 Saudi Arabia    
  10.6.2 UAE     
  10.6.3 Qatar     
  10.6.4 South Africa    
  10.6.5 Rest of Middle East & Africa   
        
11 Key Developments      
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 11.2 Acquisitions & Mergers    
 11.3 New Product Launch    
 11.4 Expansions     
 11.5 Other Key Strategies    
        
12 Company Profiling      
 12.1 McKesson Corporation    
 12.2 Koninklijke Philips N.V.    
 12.3 Cerner Corporation     
 12.4 Allscripts Healthcare, LLC    
 12.5 Siemens Healthineers GmbH    
 12.6 NextGen Healthcare Inc.    
 12.7 Wolters Kluwer N.V.    
 12.8 Agfa-Gevaert Group     
 12.9 Athenahealth, Inc.     
 12.10 IBM Corporation     
 12.11 Change Healthcare     
 12.12 Meditech      
 12.13 Epic Systems Corporation    
 12.14 Carestream     

List of Tables       
1 Global Clinical Decision Support Systems Market Outlook, By Region (2021-2030) ($MN)
2 Global Clinical Decision Support Systems Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Clinical Decision Support Systems Market Outlook, By Knowledge-Based Systems (2021-2030) ($MN)
4 Global Clinical Decision Support Systems Market Outlook, By Non-Knowledge-Based Systems (2021-2030) ($MN)
5 Global Clinical Decision Support Systems Market Outlook, By Interoperable Systems (2021-2030) ($MN)
6 Global Clinical Decision Support Systems Market Outlook, By Other Product Types (2021-2030) ($MN)
7 Global Clinical Decision Support Systems Market Outlook, By Component (2021-2030) ($MN)
8 Global Clinical Decision Support Systems Market Outlook, By Software (2021-2030) ($MN)
9 Global Clinical Decision Support Systems Market Outlook, By Hardware (2021-2030) ($MN)
10 Global Clinical Decision Support Systems Market Outlook, By Services (2021-2030) ($MN)
11 Global Clinical Decision Support Systems Market Outlook, By Mode of Delivery (2021-2030) ($MN)
12 Global Clinical Decision Support Systems Market Outlook, By On Premise (2021-2030) ($MN)
13 Global Clinical Decision Support Systems Market Outlook, By Web Based (2021-2030) ($MN)
14 Global Clinical Decision Support Systems Market Outlook, By Cloud Based (2021-2030) ($MN)
15 Global Clinical Decision Support Systems Market Outlook, By Application (2021-2030) ($MN)
16 Global Clinical Decision Support Systems Market Outlook, By Drug Allergy Alerts (2021-2030) ($MN)
17 Global Clinical Decision Support Systems Market Outlook, By Drug-Drug Interactions (2021-2030) ($MN)
18 Global Clinical Decision Support Systems Market Outlook, By Clinical Reminders (2021-2030) ($MN)
19 Global Clinical Decision Support Systems Market Outlook, By Clinical Guidelines (2021-2030) ($MN)
20 Global Clinical Decision Support Systems Market Outlook, By Drug Dosing Support (2021-2030) ($MN)
21 Global Clinical Decision Support Systems Market Outlook, By Other Applications (2021-2030) ($MN)
22 Global Clinical Decision Support Systems Market Outlook, By End User (2021-2030) ($MN)
23 Global Clinical Decision Support Systems Market Outlook, By Pharmacies (2021-2030) ($MN)
24 Global Clinical Decision Support Systems Market Outlook, By Hospitals (2021-2030) ($MN)
25 Global Clinical Decision Support Systems Market Outlook, By Clinics (2021-2030) ($MN)
26 Global Clinical Decision Support Systems Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
27 Global Clinical Decision Support Systems Market Outlook, By Ambulatory Surgical Centres (2021-2030) ($MN)
28 Global Clinical Decision Support Systems Market Outlook, By Other End Users (2021-2030) ($MN)
        
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials